Drug intelligence / Profile preview

sodium phosphate, dibasic + sodium phosphate, monobasic

Development stage
Unknown
Lead developer
Salix Pharmaceuticals
Modality
Small Molecules
Administration
Oral, Intravenous, Rectal
01

Overview

**Sodium phosphate, dibasic + sodium phosphate, monobasic** is a combination oral or injectable drug comprised of sodium phosphate dibasic (disodium phosphate) and sodium phosphate monobasic (monosodium phosphate). It acts as an **osmotic laxative** by increasing fluid retention in the intestinal lumen, resulting in loose stools and subsequent bowel evacuation. The combination is primarily indicated for colon cleansing prior to colonoscopy in adults, and for the treatment or prevention of hypophosphatemia in patients who cannot receive oral phosphate supplements. As a phosphate replacement, it serves to restore low blood phosphorus. The mechanism involves drawing water into the intestines via osmotic effects of sodium ions, triggering diarrhea and effective bowel cleansing. It may also be administered intravenously as a phosphate additive in fluid preparations for patients with restricted oral intake[2][3][5][7].

Brand names
OsmoPrep
Other names
Monobasic Sodium Phosphate and Dibasic Sodium Phosphate Tabletssodium phosphate tablets

Beyond the preview

Go deeper on sodium phosphate, dibasic + sodium phosphate, monobasic.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sodium phosphate, dibasic + sodium phosphate, monobasic.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call